Osteopore Ltd - Asset Resilience Ratio
Osteopore Ltd (OSX) has an Asset Resilience Ratio of 22.60% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Osteopore Ltd (OSX) strategic investment index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2025)
This chart shows how Osteopore Ltd's Asset Resilience Ratio has changed over time. See OSX net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Osteopore Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see OSX market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$626.97K | 22.6% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$626.97K | 22.60% |
Asset Resilience Insights
- Good Liquidity Position: Osteopore Ltd maintains a healthy 22.60% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Osteopore Ltd Industry Peers by Asset Resilience Ratio
Compare Osteopore Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
Ocumetics Technology Corp
V:OTC |
Medical Instruments & Supplies | 0.00% |
|
ZEN Graphene Solutions Ltd
V:ZEN |
Medical Instruments & Supplies | 4.79% |
Annual Asset Resilience Ratio for Osteopore Ltd (2018–2025)
The table below shows the annual Asset Resilience Ratio data for Osteopore Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.21% | AU$5.92K ≈ $4.19K |
AU$2.77 Million ≈ $1.96 Million |
+0.03pp |
| 2024-12-31 | 0.18% | AU$5.75K ≈ $4.07K |
AU$3.13 Million ≈ $2.22 Million |
+0.02pp |
| 2023-12-31 | 0.17% | AU$5.56K ≈ $3.93K |
AU$3.34 Million ≈ $2.37 Million |
-0.35pp |
| 2022-12-31 | 0.51% | AU$18.52K ≈ $13.11K |
AU$3.62 Million ≈ $2.56 Million |
-2.85pp |
| 2021-12-31 | 3.36% | AU$201.62K ≈ $142.66K |
AU$6.01 Million ≈ $4.25 Million |
+3.20pp |
| 2020-12-31 | 0.16% | AU$16.40K ≈ $11.60K |
AU$10.25 Million ≈ $7.25 Million |
-0.21pp |
| 2019-12-31 | 0.37% | AU$15.79K ≈ $11.17K |
AU$4.28 Million ≈ $3.03 Million |
+0.18pp |
| 2018-12-31 | 0.18% | AU$9.94K ≈ $7.03K |
AU$5.40 Million ≈ $3.82 Million |
-- |
About Osteopore Ltd
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, United Arab Emirates, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its tech… Read more